Speakers

Adam Savitz

Chief Medical Officer

Alto Neuroscience

Andrew Miller

Founder & President, Research & Development

Karuna Therapeutics

Dan Smith

Executive Director, Head of Translational Medicine

Alkermes

Hadile Ounallah Saad

Head of Innovation & Early-Stage Pipeline

Clexio Biosciences

Hannah Brown

Clinical Associate Professor, Psychiatry

Boston University (Researcher for Phase 3 Adjunctive KarXT trial)

Harri Jarvelainen

Chief Executive Officer

Aivo Biosciences

Jenny Barnett

Chief Executive Officer

Monument Therapeutics

Jonathan Javitt

Chief Executive Officer

NRx Pharmaceuticals

Kiri Granger

Chief Scientific Officer

Monument Therapeutics

Laxminarayan Bhat

Founder, President, Chief Executive Officer

Reviva Pharmaceuticals

Mikhail Kalinichev

Head of Translational Science

Neurosterix

Neel Desai

Business Development & Licensing

Biogen

Nick Brandon

Chief Scientific Officer

Neumora

Pablo Lapuerta

Chief Executive Officer

4M Therapeutics Inc

Paulo Lizano

Neuropsychiatrist, Physician-Scientist, Assistant Professor in Psychiatry

Harvard Medical School

Robert Goldman

Senior Vice President, Head, Medical Affairs

MapLight Therapeutics

Shaheen Lakhan

Chief Medical Officer

Click Therapeutics

Steven Paul

Founder & Board Chair

Seaport Therapeutics (former CEO & CSO of Karuna Therapeutics)

Zhong Zhong

Chief Scientific Officer

Ovid Therapeutics

Event Guide
Register